title: Design and evaluation of a transesophageal HIFU probe for ultrasound-guided cardiac ablation: simulation of a HIFU mini-maze procedure and preliminary ex vivo trials.
abstract: Atrial fibrillation (AF) is the most frequent cardiac arrhythmia. Left atrial catheter ablation is currently performed to treat this disease. Several energy sources are used, such as radio-frequency or cryotherapy. The main target of this procedure is to isolate the pulmonary veins. However, significant complications caused by the invasive procedure are described, such as stroke, tamponade, and atrioesophageal fistula, and a second intervention is often needed to avoid atrial fibrillation recurrence. For these reasons, a minimally-invasive device allowing performance of more complex treatments is still needed. High-intensity focused ultrasound (HIFU) can cause deep tissue lesions without damaging intervening tissues. Left atrial ultrasound-guided transesophageal HIFU ablation could have the potential to become a new ablation technique. The goal of this study was to design and test a minimally-invasive ultrasound-guided transesophageal HIFU probe under realistic treatment conditions. First, numerical simulations were conducted to determine the probe geometry, and to validate the feasibility of performing an AF treatment using a HIFU mini-maze (HIFUMM) procedure. Then, a prototype was manufactured and characterized. The 18-mm-diameter probe head housing contained a 3-MHz spherical truncated HIFU transducer divided into 8 rings, with a 5-MHz commercial transesophageal echocardiography (TEE) transducer integrated in the center. Finally, ex vivo experiments were performed to test the impact of the esophagus layer between the probe and the tissue to treat, and also the influence of the lungs and the vascularization on lesion formation. First results show that this prototype successfully created ex vivo transmural myocardial lesions under ultrasound guidance, while preserving intervening tissues (such as the esophagus). Ultrasound-guided transesophageal HIFU can be a good candidate for treatment of AF in the future.
authors.forename: Elodie
authors.initials: E
authors.lastname: Constanciel
authors.forename: W Apoutou
authors.initials: WA
authors.lastname: N'Djin
authors.forename: Francis
authors.initials: F
authors.lastname: Bessière
authors.forename: Françoise
authors.initials: F
authors.lastname: Chavrier
authors.forename: Daniel
authors.initials: D
authors.lastname: Grinberg
authors.forename: Alexandre
authors.initials: A
authors.lastname: Vignot
authors.forename: Philippe
authors.initials: P
authors.lastname: Chevalier
authors.forename: Jean Yves
authors.initials: JY
authors.lastname: Chapelon
authors.forename: Cyril
authors.initials: C
authors.lastname: Lafon
mesh_terms: D000818:Animals; D006348:Cardiac Surgical Procedures / Q000295:instrumentation*; D017076:Computer-Aided Design; D004452:Echocardiography / Q000295:instrumentation*; D004867:Equipment Design; D019544:Equipment Failure Analysis; D057086:High-Intensity Focused Ultrasound Ablation / Q000295:instrumentation* / Q000379:methods; D008904:Miniaturization; D010865:Pilot Projects; D012756:Sheep; D025321:Surgery, Computer-Assisted / Q000295:instrumentation* / Q000379:methods; D013552:Swine; D014159:Transducers